001     177482
005     20240320150134.0
024 7 _ |a 10.1038/s41467-019-14052-x
|2 doi
024 7 _ |a pmid:32024819
|2 pmid
024 7 _ |a pmc:PMC7002770
|2 pmc
024 7 _ |a altmetric:75080893
|2 altmetric
037 _ _ |a DKFZ-2021-02569
041 _ _ |a English
082 _ _ |a 500
100 1 _ |a Bhandari, Vinayak
|0 0000-0003-0265-0835
|b 0
245 _ _ |a Divergent mutational processes distinguish hypoxic and normoxic tumours.
260 _ _ |a [London]
|c 2020
|b Nature Publishing Group UK
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1710943193_16618
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a siehe Correction: DKFZ Autoren affiliiert im PCAWG Consortium:https://inrepo02.dkfz.de/record/212440 /https://doi.org/10.1038/s41467-022-32339-4
520 _ _ |a Many primary tumours have low levels of molecular oxygen (hypoxia), and hypoxic tumours respond poorly to therapy. Pan-cancer molecular hallmarks of tumour hypoxia remain poorly understood, with limited comprehension of its associations with specific mutational processes, non-coding driver genes and evolutionary features. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2658 cancers across 38 tumour types, we quantify hypoxia in 1188 tumours spanning 27 cancer types. Elevated hypoxia associates with increased mutational load across cancer types, irrespective of underlying mutational class. The proportion of mutations attributed to several mutational signatures of unknown aetiology directly associates with the level of hypoxia, suggesting underlying mutational processes for these signatures. At the gene level, driver mutations in TP53, MYC and PTEN are enriched in hypoxic tumours, and mutations in PTEN interact with hypoxia to direct tumour evolutionary trajectories. Overall, hypoxia plays a critical role in shaping the genomic and evolutionary landscapes of cancer.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
650 _ 7 |a TP53 protein, human
|2 NLM Chemicals
650 _ 7 |a Tumor Suppressor Protein p53
|2 NLM Chemicals
650 _ 7 |a PTEN Phosphohydrolase
|0 EC 3.1.3.67
|2 NLM Chemicals
650 _ 7 |a PTEN protein, human
|0 EC 3.1.3.67
|2 NLM Chemicals
650 _ 2 |a Cell Hypoxia: genetics
|2 MeSH
650 _ 2 |a Genes, myc
|2 MeSH
650 _ 2 |a Genome, Human
|2 MeSH
650 _ 2 |a Genomic Structural Variation
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Mutation
|2 MeSH
650 _ 2 |a Neoplasms: genetics
|2 MeSH
650 _ 2 |a Neoplasms: pathology
|2 MeSH
650 _ 2 |a PTEN Phosphohydrolase: genetics
|2 MeSH
650 _ 2 |a Polymorphism, Single Nucleotide
|2 MeSH
650 _ 2 |a Tumor Hypoxia: genetics
|2 MeSH
650 _ 2 |a Tumor Microenvironment: genetics
|2 MeSH
650 _ 2 |a Tumor Suppressor Protein p53: genetics
|2 MeSH
650 _ 2 |a Whole Genome Sequencing
|2 MeSH
700 1 _ |a Li, Constance H
|0 0000-0002-5487-7225
|b 1
700 1 _ |a Bristow, Robert G
|0 0000-0002-8553-9544
|b 2
700 1 _ |a Boutros, Paul C
|0 0000-0003-0553-7520
|b 3
700 1 _ |a PCAWGConsortium
|0 P:(DE-HGF)0
|b 4
773 _ _ |a 10.1038/s41467-019-14052-x
|g Vol. 11, no. 1, p. 737
|0 PERI:(DE-600)2553671-0
|n 1
|p 737
|t Nature Communications
|v 11
|y 2020
|x 2041-1723
909 C O |p VDB
|o oai:inrepo02.dkfz.de:177482
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 4
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Functional and structural genomics
|x 0
914 1 _ |y 2020
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT COMMUN : 2019
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-02-02
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
|d 2021-02-02
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-02-02
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b NAT COMMUN : 2019
|d 2021-02-02
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-02-02
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2021-02-02
920 1 _ |0 I:(DE-He78)B080-20160331
|k B080
|l Theoretische Bioinformatik
|x 0
920 1 _ |0 I:(DE-He78)B240-20160331
|k B240
|l Bioinformatik und Omics Data Analytics
|x 1
920 1 _ |0 I:(DE-He78)B370-20160331
|k B370
|l Epigenomik
|x 2
920 1 _ |0 I:(DE-He78)B330-20160331
|k B330
|l Angewandte Bioinformatik
|x 3
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 4
920 1 _ |0 I:(DE-He78)B060-20160331
|k B060
|l B060 Molekulare Genetik
|x 5
920 1 _ |0 I:(DE-He78)B360-20160331
|k B360
|l Pädiatrische Gliomforschung
|x 6
920 1 _ |0 I:(DE-He78)BE01-20160331
|k BE01
|l DKTK Koordinierungsstelle Berlin
|x 7
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l B062 Pädiatrische Neuroonkologie
|x 8
920 1 _ |0 I:(DE-He78)B066-20160331
|k B066
|l B066 Chromatin-Netzwerke
|x 9
920 1 _ |0 I:(DE-He78)B063-20160331
|k B063
|l B063 Krebsgenomforschung
|x 10
920 1 _ |0 I:(DE-He78)W190-20160331
|k W190
|l Hochdurchsatz-Sequenzierung
|x 11
920 1 _ |0 I:(DE-He78)B260-20160331
|k B260
|l B260 Bioinformatik der Genomik und Systemgenetik
|x 12
920 1 _ |0 I:(DE-He78)W610-20160331
|k W610
|l Core Facility Omics IT
|x 13
920 1 _ |0 I:(DE-He78)B087-20160331
|k B087
|l B087 Neuroblastom Genomik
|x 14
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B080-20160331
980 _ _ |a I:(DE-He78)B240-20160331
980 _ _ |a I:(DE-He78)B370-20160331
980 _ _ |a I:(DE-He78)B330-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)B060-20160331
980 _ _ |a I:(DE-He78)B360-20160331
980 _ _ |a I:(DE-He78)BE01-20160331
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a I:(DE-He78)B066-20160331
980 _ _ |a I:(DE-He78)B063-20160331
980 _ _ |a I:(DE-He78)W190-20160331
980 _ _ |a I:(DE-He78)B260-20160331
980 _ _ |a I:(DE-He78)W610-20160331
980 _ _ |a I:(DE-He78)B087-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21